Old blood and female blood

Two recent studies caught my eye, both about blood transfusion.

The first study was published in NEJM by Cooper DJ, McQuilten ZK, Nichol A et el comparing use of freshest vs oldest available blood in critically ill patients. 

In this international, multi center, randomized, double-blind trial, critically ill adults were assigned to receive either the freshest available, compatible, allogeneic red cells (short-term storage group) or standard-issue (oldest available), compatible, allogeneic red cells (long-term storage group). The primary outcome was 90-day mortality.

Among the 2457 patients in the short-term storage group, the mean storage duration was 11.8 days. Among the 2462 patients in the long-term storage group, the mean storage duration was 22.4 days. At 90 days, there were 610 deaths (24.8%) in the short-term storage group and 594 (24.1%) in the long-term storage group (absolute risk difference, 0.7 percentage points; 95% confidence interval [CI], -1.7 to 3.1; P=0.57).

In other interesting study, published by Camila Caram-Deelder , Aukje L. Kreuger et el in JAMA.

In this cohort study conducted in 6 Dutch hospitals, that included 31 118 patients who received red blood cell transfusions, receipt of a transfusion from an ever-pregnant female donor was associated with a statistically significant increase in all-cause mortality among male recipients of red blood cell transfusions (hazard ratio, 1.13) but not among female recipients (hazard ratio, 0.99).

As with any cohort studies, it may be a pointer towards a causation but needs to be investigated further with more studies. Furthermore, if it stands true, we need to understand the mechanism.


Pantoprazole reduces GI bleeding in intubated patients without improving mortality.Read more